-
psnet.ahrq.gov/issue/medication-related-clinical-decision-support-alert-overrides-inpatients
July 16, 2019 - While nearly all duplicate drug alert and drug allergy overrides were appropriate, most renal or age
-
psnet.ahrq.gov/node/33669/psn-pdf
May 01, 2018 - products warn prescribers of problems related to total drug
dose, duplicate therapy, patient weight, renal … target goals, and
subsequently expanded our study to include several dozen medications affected by renal
-
psnet.ahrq.gov/issue/ambiguous-abbreviations-audit-abbreviations-paediatric-note-keeping
November 16, 2022 - July 16, 2014
Electronic prescribing reduced prescribing errors in a pediatric renal
-
psnet.ahrq.gov/issue/emotional-fallout-culture-blame-and-shame
October 28, 2020 - January 17, 2024
Ordering of continuous renal replacement therapy in a computerized provider
-
psnet.ahrq.gov/issue/improving-medication-safety-icu-pharmacists-role
April 20, 2022 - June 16, 2019
Ordering of continuous renal replacement therapy in a computerized provider
-
psnet.ahrq.gov/issue/automatic-errors-case-series-errors-inherent-electronic-prescribing
March 14, 2022 - January 14, 2011
Electronic prescribing reduced prescribing errors in a pediatric renal
-
psnet.ahrq.gov/issue/oversight-hearing-recent-patient-safety-issues
November 06, 2019 - November 6, 2019
Hearing on Patient Safety and Quality Issues in End Stage Renal Disease
-
psnet.ahrq.gov/issue/examining-status-vas-electronic-health-record-modernization-program
November 10, 2021 - July 22, 2020
Hearing on Patient Safety and Quality Issues in End Stage Renal Disease
-
psnet.ahrq.gov/issue/minimising-medication-errors-children
August 04, 2021 - June 17, 2014
Ordering of continuous renal replacement therapy in a computerized provider
-
psnet.ahrq.gov/issue/pros-and-cons-ehr-clinical-decision-support-alerts
August 25, 2021 - April 7, 2022
Renal medication-related clinical decision support (CDS) alerts and
-
psnet.ahrq.gov/issue/focus-computerized-provider-order-entry
March 11, 2020 - March 8, 2023
Renal medication-related clinical decision support (CDS) alerts and overrides
-
psnet.ahrq.gov/issue/different-roles-same-goal-risk-and-quality-management-partnering-patient-safety-ashrm
January 27, 2021 - October 17, 2012
Renal medication-related clinical decision support (CDS) alerts and
-
psnet.ahrq.gov/issue/implementing-electronic-medical-record-computerized-prescriber-order-entry-critical-access
August 21, 2024 - May 24, 2015
Ordering of continuous renal replacement therapy in a computerized provider
-
psnet.ahrq.gov/issue/prescribing-errors-low-molecular-weight-heparins
July 26, 2017 - study identified prescribing errors – primarily lack of dosage adjustment for body weight and/or renal
-
psnet.ahrq.gov/issue/medication-errors-antituberculosis-therapy-inpatient-academic-setting-forgotten-not-gone
April 27, 2016 - The most common errors were due to inadequate dosing adjustments for weight, renal insufficiency, or
-
psnet.ahrq.gov/issue/seeking-systems-based-facilitators-safety-and-healthcare-resilience-thematic-review-incident
December 06, 2023 - December 21, 2017
Electronic prescribing reduced prescribing errors in a pediatric renal
-
psnet.ahrq.gov/issue/overview-adverse-events-related-invasive-procedures-intensive-care-unit
November 29, 2023 - June 1, 2022
Effect of alerts for drug dosage adjustment in inpatients with renal insufficiency
-
psnet.ahrq.gov/issue/health-care-workers-midst-crisis
February 15, 2023 - March 11, 2020
Renal medication-related clinical decision support (CDS) alerts and overrides
-
psnet.ahrq.gov/web-mm/bowel-prep
March 01, 2017 - Oral sodium phosphate preparations should not be used in patients with renal disease, congestive heart … if the patient has one of the medical conditions that would preclude the use of this agent, such as renal … contraindications of sodium phosphate preparations; institutions with a high prevalence of cardiac and renal
-
psnet.ahrq.gov/node/857260/psn-pdf
November 30, 2023 - co-transporter-2 inhibitors (SGLT2i).1,2 SGLT2i represent a class of medications that work
on the renal … acids, and ketone production.3,4
The use of SGLT2is in patients with diabetes, cardiovascular, and renal … SGLT2 inhibitor induced euglycemic DKA (EDKA) with
proximal renal tubular acidosis (RTA) as a rare fatal